癌症免疫疗法
信使核糖核酸
癌症治疗
癌症
免疫疗法
计算生物学
医学
生物信息学
癌症研究
纳米技术
生物
基因
内科学
遗传学
材料科学
作者
Yin Li,Hengtong Fang,Tao Zhang,Yu Wang,Tingting Qi,Bai Li,Huping Jiao
标识
DOI:10.3389/fbioe.2022.1053197
摘要
Intracellular delivery of message RNA (mRNA) technique has ushered in a hopeful era with the successive authorization of two mRNA vaccines for the Coronavirus disease-19 (COVID-19) pandemic. A wide range of clinical studies are proceeding and will be initiated in the foreseeable future to treat and prevent cancers. However, efficient and non-toxic delivery of therapeutic mRNAs maintains the key limited step for their widespread applications in human beings. mRNA delivery systems are in urgent demand to resolve this difficulty. Recently lipid nanoparticles (LNPs) vehicles have prospered as powerful mRNA delivery tools, enabling their potential applications in malignant tumors via cancer immunotherapy and CRISPR/Cas9-based gene editing technique. This review discusses formulation components of mRNA-LNPs, summarizes the latest findings of mRNA cancer therapy, highlights challenges, and offers directions for more effective nanotherapeutics for cancer patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI